Maidihao
Ordered peptides from Maidihao? Mail in a sample (US only) and let us test it.
Test my supplyMaidihao's purity-focus record is strongest in Retatrutide, where later lots recovered to high purity with acceptable fills after a severe early purity miss. Tesamorelin is weaker because of a major underfill despite identity and purity, and the recent two-peptide evidence base remains narrow and dispersed by batch-ID gaps.
Corporate records tie Maidihao to a revoked Shenzhen trading company, while the storefront sits on a Shop910 stack built for cloaking and redirect rotation. The report maps borrowed sister-brand assets, placeholder support channels, and exposed payment rails.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Maidihao rows.
Cancel anytime
Ordered peptides from Maidihao? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
28 Apr 2026 | Fail | Tesamorelin Maidihao | lab name | View COA | |||
18 Mar 2026 | Pass | Tirzepatide Maidihao | lab name | View COA | |||
6 Mar 2026 | Fail | Tirzepatide Maidihao | lab name | View COA | |||
6 Mar 2026 | Pass | Tesamorelin Maidihao | lab name | View COA | |||
26 Feb 2026 | Pass | Retatrutide Maidihao | lab name | View COA | |||
15 Feb 2026 | Pass | Retatrutide Maidihao | lab name | View COA | |||
15 Feb 2026 | Pass | Tesamorelin Maidihao | lab name | View COA | |||
11 Feb 2026 | Pass | Tirzepatide Maidihao | lab name | View COA | |||
19 Jan 2026 | Fail | Retatrutide Maidihao | lab name | View COA | |||
1 Jan 2026 | Pass | Retatrutide Maidihao | lab name | View COA | |||
About Maidihao test results from Finnrick
Maidihao is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 12 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Maidihao peptides in this dataset are Retatrutide (5 tests), Tesamorelin (4 tests) and Tirzepatide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 12 recent tests.
Ordered peptides from Maidihao? Mail in a sample (US only) and let us test it.
Test my supply